OUR EXPERTS

Meet the driving force at Imbiosol
bt_bb_section_bottom_section_coverage_image
“As our company strives to transcend globally, we aim at providing the best facilities including infrastructure and laboratory practices to our clients across all continents. We are committed at delivering the highest standards based on international legal & ethical practices”

Sc. Prajakta S

Scientific Director, Stem Cell Scientist & Regenerative Medicine Practitioner

About Sc. Prajakta S

Prajakta is one of the “World’s Top Stem Cell Scientists & Regenerative Medical Practitioner” and wears her pride with honor in converting stem cell research into applicable autologous regenerative medical treatments available to public health. Prajakta was one of the first to collaborate Stem cell treatments into practice in UK and India. She is a former Clinical embryologist who later found a keen penchant for Stem cell research and medicine.

Prajakta’s cohesive abilities sets her apart with her avid interest in laboratory set ups, experience in regulatory body approvals, clinical research and medical lab assimilation.

She specializes in using stem cells from the bone marrow, adipose tissue and blood for autologous therapies and treatments. Her passion for developing start – up labs by transforming them to full-fledged working laboratories for research and commercial aspects is what keeps Prajakta to bring new ventures to IMBIOSOL.

She aims at expanding the business into many other labs such as Invitro fertilization labs, Orth biologics research labs, cord blood banking labs, converting the company space to state-of the art training and execution center with the best industry standards for a medical training laboratory.

https://secureservercdn.net/160.153.137.170/cvz.9db.myftpupload.com/wp-content/uploads/2020/07/20200718_194442_0000.png?time=1614653722
bt_bb_section_top_section_coverage_image
https://secureservercdn.net/160.153.137.170/cvz.9db.myftpupload.com/wp-content/uploads/2020/08/20200824_184654_0000-640x640.png
"I bring my 20 years of experience in the field of medicine and healthcare to IMBIOSOL which has been greatly applied in elevating hospital operations by using the IMBIOSOL laboratories services"

Dr. Azhar Aslam

Medical Director

About Dr. Azhar Aslam

Azhar Aslam is the current President of the British Association of Cosmetic Surgeons (BACS). Azhar trained in Surgery for ten years; out of which five and a half years was in Plastic Surgery in the NHS. Pursuing his chosen speciality of Plastic Surgery, he was awarded a scholarship by the Royal College of Surgeons and Physicians, Glasgow, which took him to Louisiana, USA, for a Fellowship in 1996. He furthered his expertise in Cosmetic Surgery, training and working in America, Mexico and Germany, obtaining a Fellowship of the American College of Surgeons in 1999.

It is imperative then, that the results of the analysis can be trusted, in terms of their accuracy and reproducibility. For a number of reasons – usually linked to ensuring a product has been manufactured to meet specifications.

Azhar continued to work in the NHS, finally working as Consultant Plastic Surgeon at the Countess of Chester Hospital in Chester, where he helped set up a specialist hand unit. He left the NHS in 2000 to work privately and has since built up a private Cosmetic Surgery practice and a Health Village in Harley Street, London. Azhar works from other clinics located across the UK as well. He has worked actively with the Department of Health, IHA and expert groups to improve the regulation of the cosmetic surgery industry. He has worked as panel advisor to the European Academy for Cosmetic Surgery and as Academic Secretary of the British Association of Cosmetic Surgeons, recently becoming President.

bt_bb_section_top_section_coverage_image
“ Every growing organisation comes with a diverse pool of knowledgeable professionals, however, requiring a fresher outlook which is what I bring to IMBIOSOL in order to achieve the finesse & expertise”

Dr. Kausar V

Head of Laboratory

About Dr. Kausar V

Renowned for her expertise in aesthetic medicine, Kausar is a dynamic and versatile dermatologist and aesthetic practitioner with a keen interest in optimizing the approach towards clinical and aesthetic dermatology.

An avid believer of promoting aesthetic medicine through digital platforms, Kausar has spearheaded her practice with her unrivalled precision and her obsession for creating outstanding natural results when it comes to patient satisfaction.

She believes in creating a unique facial rejuvenation experience using her expertise in state-of the -art, biological natural fillers, cellular treatments, and bio-plasma treatments performed by  Kausar herself in order to meet her highly- elevated  standards that are above par within the Aesthetic industry.

An ardent researcher, Dr. Kausar values her interest in exploring treatments using mesenchymal stem cells for vitiligo , hair loss and wound healing. Apart from her skills, she also promotes an interactive learning and training environment for her assistant fellow doctors and nurses, which is one of the key responsibilities in full-filling any project at IMBIOSOL. She is known to create an atmosphere of integrated learning and mutual growth amongst her trainees.  As well as pioneering new technologies and aesthetic concepts , Kausar has many publications in national and international journals. She actively participates in Dermatology Conferences that keeps her at pace with the current trends. Her sound background allows her to transcend and bring various practices and technological breakthroughs to IMBIOSOL that in turn readily makes it available to our clients.

https://secureservercdn.net/160.153.137.170/cvz.9db.myftpupload.com/wp-content/uploads/2020/08/20200824_184654_0002.png?time=1614653722
https://secureservercdn.net/160.153.137.170/cvz.9db.myftpupload.com/wp-content/uploads/2020/08/20200824_184654_0001.png?time=1614653722
“As technology changes in our world, IMBIOSOL will continue to lead in innovation and research laboratory services, with an unwavering dedication helping scientists & industry leaders achieve research in a thoughtful & stress-free manner”

Tomas P

Executive Director

About Tomas

A charismatic entrepreneur, Tomas is a real estate investor, working with national health services over 15 years supporting community health. Tomas passionately develops businesses that resonate and work towards prioritizing public health by merging science, health and innovation by making it a mere possibility. He enjoys working towards developing digital health, fitness health, nutritional health & mindfulness.

Tomas is passionately working towards uplifting the company’s current business strategies whilst executing innovative advancements that benefit IMBIOSOL.

He’s highly passionate in promoting seamless digital health and bring the easy-life to consumers.

Tomas strives in ensuring the company delivers an uncompromised commitment to service qualities, innovation, medical, health & digital platforms making IMBIOSOL stand apart.

bt_bb_section_top_section_coverage_image
"I greatly appreciate the communication on the process, what we needed to do in terms of providing samples, what to expect from testing."
https://secureservercdn.net/160.153.137.170/cvz.9db.myftpupload.com/wp-content/uploads/2020/04/signature.png?time=1614653722

Dr. Deepak B

Head of Laboratory
https://secureservercdn.net/160.153.137.170/cvz.9db.myftpupload.com/wp-content/uploads/2020/04/signature.png?time=1614653722

About Dr. Deepak B

Deepak is a renowned clinical researcher and a healthcare business consultant . With an experience of more than 10 years, Deepak has pioneered the Stem Cell and Regenerative Medicine industry in South East Asia by successfully implementing the Stem Cell Banking Industry in India.

IMBIOSOL India is strategically managed under Deepak’s leadership qualities where he boldly practices effective Value Chains to strive IMBIOSOL in the right direction.

Deepak has established some of India’s award winning businesses specially CRO for Standardisation of Generic Molecules using Bio-Availability & Bio -Equivalance Study Centres.

Deepak has also spearheaded many Drug Development Projects of New Molecules in their Phase 1 and Phase 2 Trial phases.

Deepak brings his enduring freedom of business to IMBIOSOL and envisions the company’s growth upon his shoulders.

https://secureservercdn.net/160.153.137.170/cvz.9db.myftpupload.com/wp-content/uploads/2020/07/AGG7553-copy.jpg?time=1614653722
bt_bb_section_top_section_coverage_image
https://secureservercdn.net/160.153.137.170/cvz.9db.myftpupload.com/wp-content/uploads/2020/07/4V6A9019-scaled.jpg?time=1614653722
“As a research pathologist, I try to keep myself competing with trending technological advancements in the medical field to minimise the errors of diagnosis. This helps me to add value to an organisation such a IMBIOSOL which gives me the opportunity to highlight error -free trusted advancements that would suit the company in in order to acquire the right market trust and value in itself”
https://secureservercdn.net/160.153.137.170/cvz.9db.myftpupload.com/wp-content/uploads/2020/04/signature.png?time=1614653722

Dr. Komal K

Dr. Komal Kapoor, Director, Research pathologist for Developments
https://secureservercdn.net/160.153.137.170/cvz.9db.myftpupload.com/wp-content/uploads/2020/04/signature.png?time=1614653722

Dr. Komal K

A research pathologist aspiring to bring about dynamic changes to the world of haematological diagnosis, Komal values cohesive multi-disciplinary working environments practiced at IMBIOSOL.  She is one of those few unprejudiced medical professionals who values collaborative approaches to bring the best of health diagnosis through the many products of IMBIOSOL. Komal has been a proactive member of the board striving to soar IMBIOSOL at great heights.

Komal specialises in studying samples and performing routine biochemistry, serology, haematology, histopathology and clinical pathology across reputed hospitals and laboratories.

Apart from being passionate about her skills, Komal is a qualified  NABL QMS & IA certified professional with NABL approved authorised signatory. Her substantial experience in  managing blood banks, FNAC procedures and playing a key role during the annual NABL and NABH audits at the hospitals is what truly sets her apart.

What also makes Komal stand apart is her ability to work with the changing world & excel in her area of expertise. Her continuous ability to excel at trending new ways of keeping up with pathological diagnosis such as digital pathology which includes e-slide scanners is what keeps her at pace with current times.

Komal’s research background is worth a praise with her ground breaking publications in solid tumours and a Cytohistomorphological dissertation on various breast lesions on over 200 cases. She has validated and standardised different assays in areas of IHC, H&E and IPF (Immature platelet fraction).  Komal loves polishing her laboratory skills by actively gaining hands- on experience in innovative diagnostical studies and her recent experience with molecular genetics has peeked her interest due to the subject’s demand and affinity towards becoming a futuristic approach towards diagnostic pathology, known to validate the accuracy of pathological diagnostic studies.

bt_bb_section_top_section_coverage_image
"I greatly appreciate the communication on the process, what we needed to do in terms of providing samples, what to expect from testing."
https://secureservercdn.net/160.153.137.170/cvz.9db.myftpupload.com/wp-content/uploads/2020/04/signature.png?time=1614653722

Vijay R

Founder, Finance Director
https://secureservercdn.net/160.153.137.170/cvz.9db.myftpupload.com/wp-content/uploads/2020/04/signature.png?time=1614653722

About Vijay R

Laboratory analysis may be carried out for a number of reasons – usually linked to ensuring a product has been manufactured to meet specifications and regulations and is safe to be released to the market place.

It is imperative then, that the results of the analysis can be trusted, in terms of their accuracy and reproducibility. For a number of reasons – usually linked to ensuring a product has been manufactured to meet specifications.

She has developed assays in the following areas; UPLC-MS/MS, GC-FID, in vivo microdialysis, HPLC-(UV, fluorescence, electrochemical), 2D-gel electrophoresis, metabolite tracing using radio labelled isotopes. RIA and EIA, and has over twenty academic publications.

Regulations and is safe to be released to the market place. It is imperative then, that the results of the analysis can be trusted, in terms of their accuracy and reproducibility.

https://secureservercdn.net/160.153.137.170/cvz.9db.myftpupload.com/wp-content/uploads/2020/07/ILS6885.jpg?time=1614653722
bt_bb_section_top_section_coverage_image
https://secureservercdn.net/160.153.137.170/cvz.9db.myftpupload.com/wp-content/uploads/2020/04/about-me-03.jpg?time=1614653722

Biography and achievements

She has developed essays in the following areas: UPLC-MS/MS, GC-FID, in vivo microdialysis, HPLC-(UV, fluorescence, electrochemical), 2D-gel electrophoresis.
Clinical Areas

Podcasting operational change management inside of workflows to establish a framework. Taking seamless key performance indicators offline to maximise the long tail. Keeping your eye on the ball while performing a deep dive on the start-up mentality to derive convergence on cross-platform integration.

Collaboratively administrate empowered markets via plug-and-play networks. Dynamically procrastinate B2C users after installed base benefits. Dramatically visualize customer directed convergence without revolutionary ROI.

Research and Publications

Podcasting operational change management inside of workflows to establish a framework. Taking seamless key performance indicators offline to maximise the long tail. Keeping your eye on the ball while performing a deep dive on the start-up mentality to derive convergence on cross-platform integration.

Collaboratively administrate empowered markets via plug-and-play networks. Dynamically procrastinate B2C users after installed base benefits. Dramatically visualize customer directed convergence without revolutionary ROI.

Licences

Podcasting operational change management inside of workflows to establish a framework. Taking seamless key performance indicators offline to maximise the long tail. Keeping your eye on the ball while performing a deep dive on the start-up mentality to derive convergence on cross-platform integration.

Collaboratively administrate empowered markets via plug-and-play networks. Dynamically procrastinate B2C users after installed base benefits. Dramatically visualize customer directed convergence without revolutionary ROI.

Achievements

Podcasting operational change management inside of workflows to establish a framework. Taking seamless key performance indicators offline to maximise the long tail. Keeping your eye on the ball while performing a deep dive on the start-up mentality to derive convergence on cross-platform integration.

Collaboratively administrate empowered markets via plug-and-play networks. Dynamically procrastinate B2C users after installed base benefits. Dramatically visualize customer directed convergence without revolutionary ROI.

Education

Podcasting operational change management inside of workflows to establish a framework. Taking seamless key performance indicators offline to maximise the long tail. Keeping your eye on the ball while performing a deep dive on the start-up mentality to derive convergence on cross-platform integration.

Collaboratively administrate empowered markets via plug-and-play networks. Dynamically procrastinate B2C users after installed base benefits. Dramatically visualize customer directed convergence without revolutionary ROI.

bt_bb_section_top_section_coverage_image

OUR TEAMNovalab provides fast, accurate testing

bt_bb_section_top_section_coverage_image